Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of leukemia with histone deacetylase inhibitors

Treatment of leukemia with histone deacetylase inhibitors

US Patent 9833466 · Granted Dec 5, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD32024
HDAC inhibitors, alone or in combination with BTK inhibitors, for treating chron2023
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a BCL2023
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a pro2022
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD32022
Methods of use and pharmaceutical combinations of histone deacetylase inhibitors2022
Combinations of histone deacetylase inhibitors and either HER2 inhibitors or PI32020
Combinations of histone deacetylase inhibitors and either HER2 inhibitors or PI32020
Combinations of histone deacetylase inhibitors and either HER2 inhibitors or PI32020
Biomarkers to identify patients that will respond to treatment and treating such2020
Combinations of histone deacetylase inhibitors and immunomodulatory drugs2018
Biomarkers to identify patients that will respond to treatment and treating such2017